The future of IT & AI

Image
 In the not-so-distant future, the world of IT will have undergone a seismic shift. Gone were the days of traditional employment, where companies hires full-time employees to fill specific roles. Instead, the gig economy had taken over, and IT professionals will be embracing the freedom and flexibility that cames with freelancing. Companies had caught on to the benefits of project-based hiring, where they could tap into a global talent pool and scale up or down as needed. Job postings  floated online, and skilled freelancers would bid on projects that matches their expertise. Seasoned IT professionals, making the transition to freelancing in these  years, builds reputations on these  platforms like Toptal and Upwork, and their calendars will always be filled with exciting projects. Skilled  IT engineers helps big compernies to launch their new products. Their projects, some  complex, with tight deadlines, and the clients willing to pay top dollar for the ri...

Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine By Reuters• 14 February 2021 A Pfizer vaccine will be rolled out to every state i

 

JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.

Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.

The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.

“It shows unequivocally that Pfizer’s coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,” said Ran Balicer, Clalit’s chief innovation officer.

He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany’s BioNTech, is even more effective two weeks or more after the second shot.

Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated – aged 60 or older – was seen for the first time in those aged 55 and older.

Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.

Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity. (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)


Comments

Popular posts from this blog

MultiChoice’s BEE scheme trying to find 22 000 shareholders who are missing out on millions

Car Hijackings in South Africa.

MOTORS MARINE MAY 7, 2021 Boat of the Week: This 171-Foot Super-Luxe Sportfishing Yacht Is the Largest in the World